Outlook Therapeutics
OTLK
#8551
Rank
โ‚น24.19 B
Marketcap
โ‚น129.41
Share price
-5.63%
Change (1 day)
-27.99%
Change (1 year)

Revenue for Outlook Therapeutics (OTLK)

Revenue in 2026 (TTM): โ‚น24.35 Million

According to Outlook Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น32.17 Million. In 2025 the company made a revenue of โ‚น18.46 Million an increase over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Outlook Therapeutics from 2015 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น24.35 M31.92%
2025 โ‚น18.46 M
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A-100%
2019 โ‚น0.50 B113.38%
2018 โ‚น0.23 B-13.44%
2017 โ‚น0.27 B75.79%
2016 โ‚น0.15 B-28.67%
2015 โ‚น0.21 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Organovo
ONVO
โ‚น13.9 M-56.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚น2.10 B 6,455.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚น57.58 B 178,904.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
โ‚น65.12 B 202,341.01% Jersey